Skip to main content
. 2018 Feb 9;13(2):e0192663. doi: 10.1371/journal.pone.0192663

Table 2. Anthropometrical and biochemical parameters of non-obese Caucasian individuals according to the presence of NAFLD.

No NAFLD
n = 58
NAFLD
n = 55
P<
Sex (m/f) 27/31 32/23 0.05
Age (years) 42.05±10.16 47.59±10.24 0.01
Body Mass Index (Kg/m2) 24.87±2.71 27.28±2.27 0.001
Waist Circumference (cm) 87.65±11.68 98.91±9.88 0.001
Hepatic Triglycerides (%) 2.37±1.39 28.94±13.82 0.001
Cholesterol (mg/dl) 192.26±43.30 194.54±40.39 NS
LDL-C (mg/dl) 112.86±35.07 114.43±36.03 NS
HDL-C (mg/dl) 61.23±14.91 51.73±15.14 0.01
Triglycerides (mg/dl) 85.81±65.75 130.50±70.09 0.01
Serum AST (IU/L) 21.86±8.02 29.05±11.05 0.01
Serum ALT (IU/L) 20.05±6.97 41.30±18.14 0.001
GGT (IU/L) 27.91±24.23 56.19±53.74 0.01
Glucose (mg/dl) 94.86±15.44 105.89±50.28 NS
Fasting serum insulin (μU/ml) 5.92±2.20 12.91±6.90 0.001
HOMA-IR 2.47±1.04 6.73±4.10 0.001
TNF-α (ρg/ml) 150.62±27.41 163.32±53.04 NS
Adiponectin (μg/ml) 14.81±8.60 7.57±7.06 0.001

ALT, alanine aminotransferase, AST, aspartate aminotransferase; BMI, body mass index; GGT, gamma-glutamyl transferase; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol; NAFLD, non-alcoholic fatty liver disease; NS, non-significant; TNFα, tumor necrosis factor-α. Data are expressed as means ± standard deviation.

P value: the chi-square test for non-continuous variables and the unpaired Student’s two-tailed t-test or nonparametric Mann-Whitney U test, as appropriate, for continuous variables.